FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3137402202> ?p ?o ?g. }

• W3137402202 endingPage "103" @default.
• W3137402202 startingPage "95" @default.
• W3137402202 abstract "Trastuzumab, a key treatment for HER2-positive breast cancer, is available in weight-based IV and fixed-dose (600 mg) SC formulations. While the Phase 3 HannaH trial indicated non-inferiority of the SC formulation, there is some concern that the target plasma concentration may not be reached in overweight/obese patients whereas low-body-weight patients may be at risk of toxicity. This scoping review evaluated whether overweight/obese patients are at risk of below-target exposure with fixed-dose SC trastuzumab, whether low-body-weight patients are at risk of increased toxicity, especially cardiotoxicity, and whether IV and SC trastuzumab are equivalent in terms of treatment-emergent adverse events (TEAEs) (e.g. infections). Thirty-seven publications that met the eligibility criteria were included. Body weight is not an important determinant of exposure to trastuzumab at steady state (i.e. pre-dose cycle 8); however, real-world evidence suggests that the target concentration (20 μg/mL) may not be reached with the first SC dose in overweight/obese patients. There is no evidence that low-body-weight patients are at increased risk of cardiotoxicity with SC trastuzumab, although this may be confounded by the higher rate of cardiovascular comorbidities in overweight patients. In Phase 3 trials, SC trastuzumab was associated with higher rates of ISRs, ADAs and SAEs, the latter often requiring hospitalization and occurring during adjuvant treatment when patients are not burdened by chemotherapy. The route of administration of trastuzumab (IV vs SC) in different treatment settings should be discussed with the patient, taking into account the risks and benefits associated with each route." @default.
• W3137402202 created "2021-03-29" @default.
• W3137402202 creator A5014416915 @default.
• W3137402202 creator A5016987068 @default.
• W3137402202 creator A5021298305 @default.
• W3137402202 creator A5046269320 @default.
• W3137402202 creator A5060511880 @default.
• W3137402202 creator A5068059897 @default.
• W3137402202 creator A5084835054 @default.
• W3137402202 date "2021-06-01" @default.
• W3137402202 modified "2023-09-26" @default.
• W3137402202 title "Is weight-based IV dosing of trastuzumab preferable to SC fixed-dose in some patients? A systematic scoping review" @default.
• W3137402202 cites W1501566740 @default.
• W3137402202 cites W1549851394 @default.
• W3137402202 cites W1568399053 @default.
• W3137402202 cites W1867807972 @default.
• W3137402202 cites W1877373250 @default.
• W3137402202 cites W1906683030 @default.
• W3137402202 cites W1978013017 @default.
• W3137402202 cites W1987625267 @default.
• W3137402202 cites W1990109324 @default.
• W3137402202 cites W2005475183 @default.
• W3137402202 cites W2015186160 @default.
• W3137402202 cites W2039983139 @default.
• W3137402202 cites W2104230136 @default.
• W3137402202 cites W2107103026 @default.
• W3137402202 cites W2111347432 @default.
• W3137402202 cites W2115527794 @default.
• W3137402202 cites W2126264646 @default.
• W3137402202 cites W2159459001 @default.
• W3137402202 cites W2164322153 @default.
• W3137402202 cites W2166242275 @default.
• W3137402202 cites W2199225218 @default.
• W3137402202 cites W2218304281 @default.
• W3137402202 cites W2269901519 @default.
• W3137402202 cites W2290552023 @default.
• W3137402202 cites W2404204869 @default.
• W3137402202 cites W2514297409 @default.
• W3137402202 cites W2588570873 @default.
• W3137402202 cites W2592800202 @default.
• W3137402202 cites W2620590125 @default.
• W3137402202 cites W2622351985 @default.
• W3137402202 cites W2688564736 @default.
• W3137402202 cites W2690037010 @default.
• W3137402202 cites W2768306885 @default.
• W3137402202 cites W2770069177 @default.
• W3137402202 cites W2808987115 @default.
• W3137402202 cites W2883519239 @default.
• W3137402202 cites W2886997484 @default.
• W3137402202 cites W2891378911 @default.
• W3137402202 cites W2892266924 @default.
• W3137402202 cites W2892750202 @default.
• W3137402202 cites W2897433423 @default.
• W3137402202 cites W2899177949 @default.
• W3137402202 cites W2901669506 @default.
• W3137402202 cites W2901818724 @default.
• W3137402202 cites W2936234467 @default.
• W3137402202 cites W2943657996 @default.
• W3137402202 cites W2947160942 @default.
• W3137402202 cites W2991792334 @default.
• W3137402202 cites W2995170112 @default.
• W3137402202 cites W2995972594 @default.
• W3137402202 cites W3000984604 @default.
• W3137402202 cites W3082764581 @default.
• W3137402202 cites W3137191916 @default.
• W3137402202 cites W4248926061 @default.
• W3137402202 cites W4294215472 @default.
• W3137402202 cites W4376453102 @default.
• W3137402202 doi "https://doi.org/10.1016/j.breast.2021.03.003" @default.
• W3137402202 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8044716" @default.
• W3137402202 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33799233" @default.
• W3137402202 hasPublicationYear "2021" @default.
• W3137402202 type Work @default.
• W3137402202 sameAs 3137402202 @default.
• W3137402202 citedByCount "4" @default.
• W3137402202 countsByYear W31374022022022 @default.
• W3137402202 countsByYear W31374022022023 @default.
• W3137402202 crossrefType "journal-article" @default.
• W3137402202 hasAuthorship W3137402202A5014416915 @default.
• W3137402202 hasAuthorship W3137402202A5016987068 @default.
• W3137402202 hasAuthorship W3137402202A5021298305 @default.
• W3137402202 hasAuthorship W3137402202A5046269320 @default.
• W3137402202 hasAuthorship W3137402202A5060511880 @default.
• W3137402202 hasAuthorship W3137402202A5068059897 @default.
• W3137402202 hasAuthorship W3137402202A5084835054 @default.
• W3137402202 hasBestOaLocation W31374022021 @default.
• W3137402202 hasConcept C121608353 @default.
• W3137402202 hasConcept C126322002 @default.
• W3137402202 hasConcept C143998085 @default.
• W3137402202 hasConcept C197934379 @default.
• W3137402202 hasConcept C2777288759 @default.
• W3137402202 hasConcept C2778233292 @default.
• W3137402202 hasConcept C2779786085 @default.
• W3137402202 hasConcept C2780221984 @default.
• W3137402202 hasConcept C2780586474 @default.
• W3137402202 hasConcept C29730261 @default.
• W3137402202 hasConcept C511355011 @default.
• W3137402202 hasConcept C530470458 @default.

• next